Vaccines have made it possible to eradicate the scourge of smallpox, promise the same for polio, and have profoundly reduced the threat posed by other diseases such as whooping cough, measles, and meningitis. What is next? There are many pathogens, autoimmune diseases, and cancers that may be promising targets for vaccine research and development. This volume provides an analytic framework and quantitative model for evaluating disease conditions that can be applied by those setting priorities for vaccine development ...
Read More
Vaccines have made it possible to eradicate the scourge of smallpox, promise the same for polio, and have profoundly reduced the threat posed by other diseases such as whooping cough, measles, and meningitis. What is next? There are many pathogens, autoimmune diseases, and cancers that may be promising targets for vaccine research and development. This volume provides an analytic framework and quantitative model for evaluating disease conditions that can be applied by those setting priorities for vaccine development over the coming decades. The committee describes an approach for comparing potential new vaccines based on their impact on morbidity and mortality and on the costs of both health care and vaccine development. The book examines: Lessons to be learned from the polio experience. Scientific advances that set the stage for new vaccines. Factors that affect how vaccines are used in the population. Value judgments and ethical questions raised by comparison of health needs and benefits. The committee provides a way to compare different forms of illness and set vaccine priorities without assigning a monetary value to lives. Their recommendations will be important to anyone involved in science policy and public health planning: policymakers, regulators, health care providers, vaccine manufacturers, and researchers.
Read Less
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Fine. Bumped edges Minor shelf wear, otherwise 'As New. ' Next day dispatch by Royal Mail. International delivery available. 1000's of satisfied customers! Please contact us with any enquiries.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very good. Bumped edges. Scratches to the cover. Next day dispatch by Royal Mail. International delivery available. 1000's of satisfied customers! Please contact us with any enquiries.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Used: Acceptable. Size: 9.3 x 6.3 x 1.4 inches; Hardback no dust jacket in clean condition. Institute of Medicine. A decision-maker's guide to setting priorities for vaccine development over the coming decade, offering an analytic framework and quantitative model for evaluation of disease conditions. Also provides a way to compare different forms of illness and set vaccine priorities without the risk of human suffering or casualty. DNLM: Vaccines. 0-309-05646-2. Isbn 0309056462.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very Good. Very Good condition. A copy that may have a few cosmetic defects. May also contain light spine creasing or a few markings such as an owner's name, short gifter's inscription or light stamp. Bundled media such as CDs, DVDs, floppy disks or access codes may not be included.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very good. Bumped edges. Scratches to the cover. Marks to the edges of the pages. Next day dispatch by Royal Mail. International delivery available. 1000's of satisfied customers! Please contact us with any enquiries.
